KKR: latest news - GoINPHARMA
Saturday, 15 December 2018 - 5:39

KKR

Chinese fund Fosun successfully acquires Gland Pharma ($1.1bn)

China-based investment fund Fosun has reviewed its $1.3bn offer to India’s drugmaker Gland Pharma, and now plans to buy 74% instead of 86%, in order to bypass Indian authorities, which few months ago blocked the transaction. India’s Committee on Economic…